These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 12112935

  • 1. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives.
    van Dam PS.
    Diabetes Metab Res Rev; 2002; 18(3):176-84. PubMed ID: 12112935
    [Abstract] [Full Text] [Related]

  • 2. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
    Cameron NE, Cotter MA.
    Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947
    [Abstract] [Full Text] [Related]

  • 3. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
    Tankova T, Koev D, Dakovska L.
    Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
    [Abstract] [Full Text] [Related]

  • 4. Neuropathy in a rat model of mild diabetes induced by multiple low doses of streptozotocin: effects of the antioxidant stobadine in comparison with a high-dose alpha-lipoic acid treatment.
    Skalská S, Kucera P, Goldenberg Z, Stefek M, Kyselová Z, Jariabka P, Gajdosíková A, Klobucníková K, Traubner P, Stolc S.
    Gen Physiol Biophys; 2010 Mar; 29(1):50-8. PubMed ID: 20371880
    [Abstract] [Full Text] [Related]

  • 5. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG, Kumar A, Sharma SS.
    Life Sci; 2006 Jul 17; 79(8):777-83. PubMed ID: 16581090
    [Abstract] [Full Text] [Related]

  • 6. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
    Nangle MR, Gibson TM, Cotter MA, Cameron NE.
    Planta Med; 2006 May 17; 72(6):494-500. PubMed ID: 16773532
    [Abstract] [Full Text] [Related]

  • 7. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
    Negrişanu G, Roşu M, Bolte B, Lefter D, Dabelea D.
    Rom J Intern Med; 1999 May 17; 37(3):297-306. PubMed ID: 15532308
    [Abstract] [Full Text] [Related]

  • 8. Diabetic neuropathy and oxidative stress.
    Pop-Busui R, Sima A, Stevens M.
    Diabetes Metab Res Rev; 2006 May 17; 22(4):257-73. PubMed ID: 16506271
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of stobadine on NCV in streptozotocin-diabetic rats: augmentation by vitamin E.
    Skalska S, Kyselova Z, Gajdosikova A, Karasu C, Stefek M, Stolc S.
    Gen Physiol Biophys; 2008 Jun 17; 27(2):106-14. PubMed ID: 18645225
    [Abstract] [Full Text] [Related]

  • 10. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
    Ziegler D, Reljanovic M, Mehnert H, Gries FA.
    Exp Clin Endocrinol Diabetes; 1999 Jun 17; 107(7):421-30. PubMed ID: 10595592
    [Abstract] [Full Text] [Related]

  • 11. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK, Kumar H S A, Sharma SS.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):164-72. PubMed ID: 17521626
    [Abstract] [Full Text] [Related]

  • 12. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
    Jin HY, Joung SJ, Park JH, Baek HS, Park TS.
    Diabet Med; 2007 Sep 30; 24(9):1034-8. PubMed ID: 17490418
    [Abstract] [Full Text] [Related]

  • 13. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sharma SS, Sayyed SG.
    Clin Exp Pharmacol Physiol; 2006 Nov 30; 33(11):1022-8. PubMed ID: 17042909
    [Abstract] [Full Text] [Related]

  • 14. Diabetic neuropathy--choices of treatment.
    Bruckner I, Bustan C, Adamescu E, Dobjanschi C.
    Rom J Intern Med; 2002 Nov 30; 40(1-4):53-60. PubMed ID: 15526540
    [Abstract] [Full Text] [Related]

  • 15. Diabetic neuropathies.
    Low PA, Suarez GA.
    Baillieres Clin Neurol; 1995 Nov 30; 4(3):401-25. PubMed ID: 8599718
    [Abstract] [Full Text] [Related]

  • 16. Can diabetic neuropathy be prevented?
    Park TS, Park JH, Baek HS.
    Diabetes Res Clin Pract; 2004 Dec 30; 66 Suppl 1():S53-6. PubMed ID: 15563981
    [Abstract] [Full Text] [Related]

  • 17. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle.
    Negi G, Kumar A, Joshi RP, Sharma SS.
    Biochem Biophys Res Commun; 2011 Apr 29; 408(1):1-5. PubMed ID: 21439933
    [Abstract] [Full Text] [Related]

  • 18. Future prevention and treatment of diabetic neuropathy.
    Tomlinson DR.
    Diabetes Metab; 1998 Nov 29; 24 Suppl 3():79-83. PubMed ID: 9881237
    [Abstract] [Full Text] [Related]

  • 19. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T, Kato Y.
    Ann N Y Acad Sci; 2005 Jun 29; 1043():440-51. PubMed ID: 16037265
    [Abstract] [Full Text] [Related]

  • 20. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
    Vereşiu IA.
    Rom J Intern Med; 2004 Jun 29; 42(2):293-9. PubMed ID: 15529620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.